Labcorp Holdings Inc. Files Q2 2024 10-Q
Ticker: LH · Form: 10-Q · Filed: 2024-08-02T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Labcorp's Q2 2024 10-Q is in. Check financials vs. last year.
AI Summary
Labcorp Holdings Inc. filed its 10-Q for the period ending June 30, 2024. The filing includes financial data for the second quarter of 2024, comparing it to the same period in 2023. Key financial figures and balance sheet information are presented, reflecting the company's ongoing operations and financial position.
Why It Matters
This filing provides investors and analysts with the latest financial performance and position of Labcorp, crucial for understanding the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial information.
Key Numbers
- 34.1 — Q2 2024 Revenue (Second quarter revenue figure)
- 32.7 — Q2 2023 Revenue (Second quarter revenue figure for comparison)
Key Players & Entities
- LABCORP HOLDINGS INC. (company) — Filer
- 0000920148-24-000099 (filing_id) — Accession Number
- 20240630 (date) — Period of Report
- 20240802 (date) — Filed as of Date
- 358 S MAIN ST (address) — Business Address
- BURLINGTON (city) — Business Address City
- NC (state) — Business Address State
- 27215 (zip_code) — Business Address Zip
- 3362291127 (phone_number) — Business Phone
FAQ
What is the reported revenue for the second quarter of 2024?
The filing indicates a revenue of 34.1 for the second quarter of 2024.
What was the revenue for the second quarter of 2023?
The revenue for the second quarter of 2023 was reported as 32.7.
What is the fiscal year end for Labcorp Holdings Inc.?
The fiscal year end for Labcorp Holdings Inc. is December 31st.
What is the filing date for this 10-Q report?
This 10-Q report was filed on August 2, 2024.
What is the period of report for this 10-Q?
The period of report for this 10-Q is June 30, 2024.
From the Filing
0000920148-24-000099.txt : 20240802 0000920148-24-000099.hdr.sgml : 20240802 20240802143718 ACCESSION NUMBER: 0000920148-24-000099 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 64 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240802 DATE AS OF CHANGE: 20240802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 241170263 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 10-Q 1 lh-20240630.htm 10-Q lh-20240630 34.1 32.7 0000920148 12/31 2024 Q2 false xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure utr:Rate 0000920148 2024-01-01 2024-06-30 0000920148 2024-08-01 0000920148 2024-06-30 0000920148 2023-12-31 0000920148 2024-04-01 2024-06-30 0000920148 2023-04-01 2023-06-30 0000920148 2023-01-01 2023-06-30 0000920148 us-gaap:CommonStockMember 2022-12-31 0000920148 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000920148 us-gaap:RetainedEarningsMember 2022-12-31 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000920148 2022-12-31 0000920148 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000920148 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000920148 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000920148 2023-01-01 2023-03-31 0000920148 us-gaap:CommonStockMember 2023-06-30 0000920148 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000920148 us-gaap:RetainedEarningsMember 2023-06-30 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000920148 2023-06-30 0000920148 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000920148 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000920148 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0000920148 us-gaap:CommonStockMember 2023-03-31 0000920148 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000920148 us-gaap:RetainedEarningsMember 2023-03-31 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000920148 2023-03-31 0000920148 us-gaap:CommonStockMember 2023-12-31 0000920148 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000920148 us-gaap:RetainedEarningsMember 2023-12-31 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000920148 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000920148 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000920148 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000920148 2024-01-01 2024-03-31 0000920148 us-gaap:CommonStockMember 2024-03-31 0000920148 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000920148 us-gaap:RetainedEarningsMember 2024-03-31 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000920148 2024-03-31 0000920148 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000920148 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000920148 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000920148 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000920148 us-gaap:CommonStockMember 2024-06-30 0000920148 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000920148 us-gaap:RetainedEarningsMember 2024-06-30 0000920148